Idiopathic intracranial hypertension: consensus guidelines on management.

Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, Krishnan A, Chavda SV, Ramalingam S, Edwards J, Hemmings K, Williamson M, Burdon MA, Hassan-Smith G, Digre K, Liu GT, Jensen RH, Sinclair AJ. · 2018

Read Idiopathic intracranial hypertension: consensus guidelines on management. by Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, Krishnan A, Chavda SV, Ramalingam S, Edwards J, Hemmings K, Williamson M, Burdon MA, Hassan-Smith G, Digre K, Liu GT, Jensen RH, Sinclair AJ. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6166610.txt.

Introduction

Mollan and co-authors present joint guidelines in Journal of Neurology, Neurosurgery, and Psychiatry on a condition where pressure inside the skull rises with no clear cause. It is called idiopathic intracranial hypertension. It can harm sight if it is not caught. Care spans many fields, and practice varied a lot.

A large expert group met from 2015 to 2017 to build national guidance for the United Kingdom. It drew on brain, eye, and surgery specialists, nurses, front-line doctors, and patient voices. The group first surveyed doctors who treat the condition. Then it reviewed the published studies in full. The guidelines cover how to spot, track, and treat the condition, aiming for one shared standard of good care.

Catalog record

CREATORMollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR, Krishnan A, Chavda SV, Ramalingam S, Edwards J, Hemmings K, Williamson M, Burdon MA, Hassan-Smith G, Digre K, Liu GT, Jensen RH, Sinclair AJ.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6166610

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Idiopathic intracranial hypertension: consensus guidelines on management By Susan P Mollan, Brendan Davies, Nick C Silver, Simon Shaw, Conor L Mallucci, Benjamin R Wakerley, Anita Krishnan, Swarupsinh V Chavda, Satheesh Ramalingam, Julie Edwards, Krystal Hemmings, Michelle Williamson Published in: Journal of Neurology, Neurosurgery, and Psychiatry DOI: 10.1136/jnnp-2017-317440 ABSTRACT Abstract The aim was to capture interdisciplinary expertise from a large group of clinicians, reflecting practice from across the UK and further, to inform subsequent development of a national consensus guidance for optimal management of idiopathic intracranial hypertension (IIH). Methods Between September 2015 and October 2017, a specialist interest group including neurology, neurosurgery, neuroradiology, ophthalmology, nursing, primary care doctors and patient representatives met. An initial UK survey of attitudes and practice in IIH was sent to a wide group of physicians and surgeons who investigate and manage IIH regularly. A comprehensive systematic literature review was performed to assemble the foundations of the statements. An international panel along with four national professional bodies, namely the Association of British Neurologists, British Association for the Study of Headache, the Society of British Neurological Surgeons and the Royal College of Ophthalmologists critically reviewed the statements. Results Over 20 questions were constructed: one based on the diagnostic principles for optimal investigation of papilloedema and 21 for the management of IIH. Three main principles were identified: (1) to treat the underlying disease; (2) to protect the vision; and (3) to minimise the headache morbidity. Statements presented provide insight to uncertainties in IIH where research opportunities exist. Conclusions In collaboration with many different specialists, professions and patient representatives, we have developed guidance statements for the investigation and management of adult IIH. Keywords: headache, benign intracran hyp, clinical neurology, neuroophthalmology, neurosurgery SCOPE This is a consensus document to provide practical information for best practice in uniform investigation and treatment strategies based on current literature and opinion from a specialist interest group (SIG) for adult idiopathic intracranial hypertension (IIH). This should increase awareness of IIH among clinicians and improve outcomes for patients. The target audience for this statement includes neurologists, ophthalmologists, neurosurgeons, radiologists, emergency medicine specialists, physicians, ear nose and throat specialists and other clinicians who investigate and manage IIH. It also contains information that will be of interest to those in primary care and other healthcare professionals. The increasing economic burden of IIH has been highlighted by a number of groups.1 2 Clear guidance will help educate the attending doctors to manage these patients appropriately. This will help reduce the repeat unsolicited emergency hospital attendances and reduce IIH-related disability. There are a number of ongoing clinical trials in IIH (https://www.clinicaltrials.gov/) and as evidence for medical and surgical management evolves in IIH this document will require timely updates. BACKGROUND IIH occurs predominantly in women and although the underlying pathogenesis is not fully understood, it has a striking association with obesity.3 The combination of raised intracranial pressure, without hydrocephalus or mass lesion, normal cerebrospinal fluid (CSF) composition and where no underlying aetiology is found are accepted criteria for the diagnosis of IIH.4 The overall age-adjusted and gender-adjusted annual incidence is increasing and was reported to be 2.4 per 100 000 within the last decade (2002–2014).5 The majority of patients presenting with IIH have symptoms that include a headache that is progressively more severe and frequent, as defined by International Classification of Headache Disorders, 3rd edition (ICHD-3) (figure 1).6 The headache phenotype is highly variable and may mimic other primary headache disorders. Other symptoms may include transient visual obscurations (unilateral or bilateral darkening of the vision typically seconds), pulsatile tinnitus, back pain, dizziness, neck pain, visual blurring, cognitive disturbances, radicular pain and typically horizontal diplopia (figure 1A)3: none of which are pathognomonic for IIH.7 Investigation and management depends on symptoms and signs and requires an interdisciplinary team approach. [Figure: Consensus in diagnosing IIH. (A) Frequency of IIH symptoms reported, adapted from Markey et al. 3 (B) IIH diagnostic criteria, adapted from Friedman et al.4 (C) IIHWOP diagnostic criteria, adapted from Friedman et al.4 (D) Headache attributed to IIH, as described by the International Classification of Headache Disorders, 3rd edition (beta version) (ICHD-3 beta).6 (E) Line figure detailing the consensus of the interpretation of LP opening pressure. Uncertainty: it needs to be recognised that this is a single LP OP measurement; and after raised ICP what is then a normal ICP for this population on repeat LP readings is unknown. CSF, cerebrospinal fluid; IIH, idiopathic intracranial hypertension; LP, lumboperitoneal.] For the individual patient, some can have permanent visual loss.8 Chronic headache significantly impacts quality of life9 10 with over half of patients with IIH reporting ongoing headaches at 12 months.11 Clinical uncertainty exists, and IIH can be misdiagnosed.12 The 2015 Cochrane review has concluded that there is lack of evidence to guide pharmacological treatment in IIH.13 Randomised clinical trials are currently infrequent in this field due to the rarity of the disease, the lack of understanding of the underlying pathological mechanisms and limited disease-modifying therapies. METHODS An SIG was formed, including neurology, neurosurgery, neuroradiology, ophthalmology, nursing, primary care doctors and patient representatives. All clinicians had expertise in managing IIH. An initial UK survey of attitudes and practice in IIH was sent to a wide group of consultants who investigate and manage IIH regularly: these included neurology, neurosurgery, neuro-ophthalmology and neuroradiology. A comprehensive systemic literature review was performed to assemble the foundations of the statements. Rigorous controlled data are sparse in IIH, and therefore, a consensus-based guide is presented. Questions were formulated (table 1). An anonymous modified Delphi process was used to obtain consensus on guidance statements. All statements below obtained consensus of 75% or above from the SIG and wider Delphi group. A completed AGREE statement is found as supplementary data (online supplementary appendix 1). [Table: Questions formulated by the ABN IIH SIG on the diagnosis and management of IIH] Supplementary file 2 jnnp-2017-317440supp002.pdf An international panel of experts in IIH (RHJ, GTL and KD) reviewed the document and a wider consultation was made with professional bodies namely the Association of British Neurologists (ABN), the Society of British Neurological Surgeons (SBNS), the Royal College of Ophthalmologists (RCOphth) and the British Association for the Study of Headache (BASH). Where there was disagreement in statement recommendations, these were debated within the SIG, and wording was altered accordingly. Specifically, to improve local outcomes for patients with IIH, audit recommendations are enclosed (online supplementary appendix 2). This document will need to be revised regularly as new evidence emerges in the field of IIH. Definitions used in the guidance are presented in table 2.14–17 [Table: Definitions of the terms used in the guidance] Supplementary file 3 jnnp-2017-317440supp003.pdf DIAGNOSTIC PRINCIPLES For optimal investigation of patients with papilloedema, there must be clear communication between clinicians for seamless joint investigation between the various specialities. The aims of investigations of papilloedema are to: - find any underlying treatable cause in a timely manner - protect the vision and ensure timely re-examination when vision is at risk - enable onward care of the patient with the input from the most appropriate experienced clinician. Q1 How should papilloedema be investigated? (figure 2) [Figure: A flow diagram of investigation of papilloedema. BMI, body mass index; IIH, idiopathic intracranial hypertension.] - Blood pressure must be measured to

Read the complete text